REFRACTORY ACUTE LYMPHOID LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boosting the Body's fight: new therapy aims to recharge Cancer-Killing cells in tough leukemia
Disease control Recruiting nowThis study is for children and young adults (ages 1-39) whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to treatment, and whose previous CAR-T cell therapy stopped working early. Researchers want to see if adding a different type of immune cell, called…
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New CAR-T therapy battle: Two-Pronged attack vs. transplant bridge for tough leukemia
Disease control Recruiting nowThis study is comparing two advanced cell therapy approaches for patients with B-cell acute lymphoblastic leukemia that has returned or not responded to previous treatments. One approach uses two different CAR-T cell infusions in sequence, while the other uses one CAR-T cell infu…
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC